{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:24:59Z","timestamp":1783131899422,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacig.2026.100701","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:12:10Z","timestamp":1776186730000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing real-world natural history of indolent systemic mastocytosis: A retrospective matched cohort study"],"prefix":"10.1016","volume":"5","author":[{"given":"Thanai","family":"Pongdee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-6407","authenticated-orcid":false,"given":"Dakota","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Scherber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Smither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purushotham","family":"Krishnappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2026.100701_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/17474086.2021.1959315","article-title":"Avapritinib for systemic mastocytosis","volume":"14","author":"Bose","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jacig.2026.100701_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacig.2026.100701_bib3","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.3390\/cancers14163942","article-title":"Clinical outcomes of adults with systemic mastocytosis: a 15-year multidisciplinary experience","volume":"14","author":"Ungerstedt","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jacig.2026.100701_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100701_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jacig.2026.100701_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population-based study (Sweden)","volume":"63","author":"Bergstrom","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jacig.2026.100701_bib7","article-title":"MASTering systemic mastocytosis: lessons learned from a large patient cohort","volume":"3","author":"Tse","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jacig.2026.100701_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaip.2024.10.021","article-title":"Patient-reported burden of indolent systemic mastocytosis in a managed care organization","volume":"13","author":"Zeiger","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100701_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients\u2019 perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jacig.2026.100701_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","article-title":"High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis","volume":"67","author":"van der Veer","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2026.100701_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100701_bib12","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/all.12920","article-title":"Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis","volume":"71","author":"van Anrooij","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2026.100701_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bone.2017.09.005","article-title":"Prevalence and risk factors for fragility fracture in systemic mastocytosis","volume":"105","author":"Degboe","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.jacig.2026.100701_bib14","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jaci.2022.04.020","article-title":"Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: are we there yet?","volume":"149","author":"Akin","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100701_bib15","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.34420","article-title":"Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: results of the TouchStone SM Patient Survey","volume":"128","author":"Mesa","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jacig.2026.100701_bib16","first-page":"48","article-title":"Prevalence of reduced bone mineral density in indolent systemic mastocytosis: UK single-centre retrospective review","volume":"204","author":"Farmer","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacig.2026.100701_bib17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cea.70101","article-title":"Patient-reported outcomes and provider perceptions of systemic mastocytosis: results from the PRISM study","volume":"55","author":"Triggiani","year":"2025","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2026.100701_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.kint.2019.11.037","article-title":"Electronic health records for the diagnosis of rare diseases","volume":"97","author":"Garcelon","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacig.2026.100701_bib19","article-title":"Estimating prevalence of rare genetic disease diagnoses using electronic health records in a children\u2019s hospital","volume":"5","author":"Herr","year":"2024","journal-title":"HGG Adv"},{"key":"10.1016\/j.jacig.2026.100701_bib20","series-title":"SciBERT: a pretrained language model for scientific text","year":"2019"},{"key":"10.1016\/j.jacig.2026.100701_bib21","article-title":"Building a best-in-class automated de-identification tool for electronic health records through ensemble learning","volume":"2","author":"Murugadoss","year":"2021","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.jacig.2026.100701_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58227","article-title":"Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis","volume":"9","author":"Wagner","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jacig.2026.100701_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100793","article-title":"Pre-existing conditions are associated with COVID-19 patients\u2019 hospitalization, despite confirmed clearance of SARS-CoV-2 virus","volume":"34","author":"Pawlowski","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacig.2026.100701_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jacig.2026.100701_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2018.1.127","article-title":"The new tool \u201cKIT\u201d in advanced systemic mastocytosis","volume":"2018","author":"Shomali","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jacig.2026.100701_bib26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaip.2019.12.007","article-title":"Natural language processing combined with ICD-9-CM codes as a novel method to study the epidemiology of allergic drug reactions","volume":"8","author":"Banerji","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100701_bib27","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.jaip.2023.04.014","article-title":"Natural language processing of pediatric progress notes for the identification of food allergy","volume":"11","author":"Bilaver","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100701_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.953886","article-title":"Prevalence of multimorbidity combinations and their association with medical costs and poor health: a population-based study of U.S. adults","volume":"10","author":"Schiltz","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jacig.2026.100701_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11606-013-2616-9","article-title":"Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness","volume":"29","author":"Zulman","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacig.2026.100701_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.iac.2018.04.006","article-title":"Patient perceptions in mast cell disorders","volume":"38","author":"Jennings","year":"2018","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:13:49Z","timestamp":1783131229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829326000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2772829326000639"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100701","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing real-world natural history of indolent systemic mastocytosis: A retrospective matched cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}